Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2023

May 16, 2023

32414_dirs_2023-05-16_78e4277f-9f0c-47ec-9231-a616360230c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2023-05-12

Reporting Person: Wendell Amy McBride (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-12 Common Stock M 25000 $9.22 Acquired 60133 Direct
2023-05-12 Common Stock M 3750 $9.22 Acquired 63883 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-12 Stock Option (right to buy) $8.57 M 25000 Disposed 2023-09-16 Common Stock (0.0) Direct
2023-05-12 Stock Option (right to buy) $8.57 M 3750 Disposed 2023-09-16 Common Stock (0.0) Direct